Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-year Results from a Comparative Effectiveness Randomized Clinical Trial

PURPOSE: Provide 2-year efficacy, safety and treatment results comparing three anti-vascular endothelial growth factor (anti-VEGF) agents for center-involved diabetic macular edema (DME) utilizing a standardized follow-up and retreatment regimen. DESIGN: Randomized clinical trial. PARTICIPANTS: 660...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ophthalmology
Main Authors: Wells, John A., Glassman, Adam R., Ayala, Allison R., Jampol, Lee M., Bressler, Neil M., Bressler, Susan B., Brucker, Alexander J., Ferris, Frederick L., Hampton, G. Robert., Jhaveri, Chirag, Melia, Michele, Beck, Roy W.
格式: Artigo
語言:Inglês
出版: 2016
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877252/
https://ncbi.nlm.nih.gov/pubmed/26935357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2016.02.022
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍